Jean‐Marc Vrigneaud

955 total citations
42 papers, 670 citations indexed

About

Jean‐Marc Vrigneaud is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Jean‐Marc Vrigneaud has authored 42 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Radiation. Recurrent topics in Jean‐Marc Vrigneaud's work include Medical Imaging Techniques and Applications (21 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Jean‐Marc Vrigneaud is often cited by papers focused on Medical Imaging Techniques and Applications (21 papers), Radiomics and Machine Learning in Medical Imaging (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Jean‐Marc Vrigneaud collaborates with scholars based in France, United States and Switzerland. Jean‐Marc Vrigneaud's co-authors include François Brunotte, Alexandre Cochet, Olivier Raguin, Mathieu Moreau, Bertrand Collin, Dominique Le Guludec, G Martet, Alina Berriolo-Riedinger, Laure Sarda‐Mantel and Olivier Humbert and has published in prestigious journals such as PLoS ONE, Scientific Reports and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Jean‐Marc Vrigneaud

40 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Marc Vrigneaud France 16 355 141 114 91 85 42 670
Nicholas J. Rotile United States 21 353 1.0× 223 1.6× 116 1.0× 105 1.2× 131 1.5× 44 907
Zhongzhen Su China 18 211 0.6× 129 0.9× 227 2.0× 211 2.3× 133 1.6× 77 912
Andrzej Cieszanowski Poland 15 283 0.8× 192 1.4× 76 0.7× 43 0.5× 116 1.4× 64 734
Gerd Wunderlich Germany 20 420 1.2× 270 1.9× 43 0.4× 127 1.4× 173 2.0× 53 852
Weijun Peng China 13 201 0.6× 307 2.2× 198 1.7× 51 0.6× 90 1.1× 21 723
Hiroaki Kurihara Japan 18 608 1.7× 195 1.4× 58 0.5× 154 1.7× 282 3.3× 71 1.1k
Olivier Raguin France 16 227 0.6× 169 1.2× 104 0.9× 124 1.4× 140 1.6× 31 610
Akinaga Sonoda Japan 14 142 0.4× 184 1.3× 194 1.7× 63 0.7× 34 0.4× 65 669
Frederik Wenz Germany 15 149 0.4× 253 1.8× 119 1.0× 179 2.0× 252 3.0× 60 980
Manon Buijs United States 22 298 0.8× 162 1.1× 136 1.2× 336 3.7× 225 2.6× 33 1.2k

Countries citing papers authored by Jean‐Marc Vrigneaud

Since Specialization
Citations

This map shows the geographic impact of Jean‐Marc Vrigneaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Marc Vrigneaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Marc Vrigneaud more than expected).

Fields of papers citing papers by Jean‐Marc Vrigneaud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Marc Vrigneaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Marc Vrigneaud. The network helps show where Jean‐Marc Vrigneaud may publish in the future.

Co-authorship network of co-authors of Jean‐Marc Vrigneaud

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Marc Vrigneaud. A scholar is included among the top collaborators of Jean‐Marc Vrigneaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Marc Vrigneaud. Jean‐Marc Vrigneaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Presles, Benoît, Charles Coutant, Isabelle Desmoulins, et al.. (2024). Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer. EJNMMI Research. 14(1). 60–60. 3 indexed citations
2.
Dygai‐Cochet, Inna, et al.. (2023). Dealing with dry waste disposal issues associated with 177mLu impurities: a long-term challenge for nuclear medicine departments. EJNMMI Physics. 10(1). 3–3. 7 indexed citations
3.
Presles, Benoît, Sarah Leclerc, Fabrice Mériaudeau, et al.. (2023). A Tumour and Liver Automatic Segmentation (ATLAS) Dataset on Contrast-Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma. Data. 8(5). 79–79. 28 indexed citations
5.
Dygai‐Cochet, Inna, et al.. (2021). Démarche d’optimisation des modalités de gestion des déchets lors des traitements au 177Lu-oxodotréotide (Lutathera®). Médecine Nucléaire. 45(5-6). 263–270. 2 indexed citations
6.
Dygai‐Cochet, Inna, Benoît Presles, Olivier Chevallier, et al.. (2021). Impact of contouring methods on pre-treatment and post-treatment dosimetry for the prediction of tumor control and survival in HCC patients treated with selective internal radiation therapy. EJNMMI Research. 11(1). 24–24. 7 indexed citations
7.
Bellaye, Pierre‐Simon, Alexandra Oudot, Jean‐Marc Vrigneaud, et al.. (2018). Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model. Contrast Media & Molecular Imaging. 2018. 1–11. 2 indexed citations
8.
Bellaye, Pierre‐Simon, Mathieu Moreau, Olivier Raguin, et al.. (2018). Radiolabeled F(ab′)2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models. Clinical & Translational Oncology. 20(12). 1557–1570. 11 indexed citations
9.
Kanoun, Salim, Olivier Humbert, Aurélie Bertaut, et al.. (2018). FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST. PLoS ONE. 13(7). e0199529–e0199529. 14 indexed citations
10.
Moreau, Mathieu, Sophie Poty, Jean‐Marc Vrigneaud, et al.. (2017). MANOTA: a promising bifunctional chelating agent for copper-64 immunoPET. Dalton Transactions. 46(42). 14659–14668. 15 indexed citations
11.
Humbert, Olivier, Jean‐Marc Riedinger, Jean‐Marc Vrigneaud, et al.. (2016). 18F-FDG PET–Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer. Journal of Nuclear Medicine. 57(11). 1707–1712. 27 indexed citations
13.
Kanoun, Salim, Ṭal Ilan, Alina Berriolo-Riedinger, et al.. (2015). Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hodgkin Lymphoma. PLoS ONE. 10(10). e0140830–e0140830. 84 indexed citations
14.
Vrigneaud, Jean‐Marc, et al.. (2013). Application of the optically stimulated luminescence (OSL) technique for mouse dosimetry in micro‐CT imaging. Medical Physics. 40(12). 122102–122102. 6 indexed citations
15.
Moreau, Mathieu, Olivier Raguin, Jean‐Marc Vrigneaud, et al.. (2012). DOTAGA-Trastuzumab. A New Antibody Conjugate Targeting HER2/Neu Antigen for Diagnostic Purposes. Bioconjugate Chemistry. 23(6). 1181–1188. 34 indexed citations
16.
Cochet, Alexandre, Jean‐Marc Vrigneaud, Claude Touzery, et al.. (2012). Evaluation of Breast Tumor Blood Flow with Dynamic First-Pass 18F-FDG PET/CT: Comparison with Angiogenesis Markers and Prognostic Factors. Journal of Nuclear Medicine. 53(4). 512–520. 47 indexed citations
17.
Sarda‐Mantel, Laure, Azzam Saleh‐Mghir, Mick M. Welling, et al.. (2007). Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections. European Journal of Nuclear Medicine and Molecular Imaging. 34(8). 1302–1309. 47 indexed citations
18.
Sarda‐Mantel, Laure, Jean‐Baptiste Michel, François Rouzet, et al.. (2005). 99mTc-annexin V and 111In-antimyosin antibody uptake in experimental myocardial infarction in rats. European Journal of Nuclear Medicine and Molecular Imaging. 33(3). 239–245. 21 indexed citations
19.
Sarda‐Mantel, Laure, J.-B. Michel, François Rouzet, et al.. (2005). 99mTc-HYNIC-Annexin-V and 111In-Antimyosin-antibody myocardial uptake after permanent coronary ligature and ischemia-reperfusion in rats. Journal of Nuclear Cardiology. 12(2). S2–S2.
20.
Sarda‐Mantel, Laure, P Loiseau, François Rouzet, et al.. (2004). Imaging apoptosis with (99m)Tc-annexin-V in experimental subacute myocarditis.. PubMed. 45(6). 1081–6. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026